Search

Author/Creator Hernández-Rivas, J.-Á.

1. P1608: EXPERIENCE AND COMPLICATIONS WITH THE USE OF PICCS IN HEMATOLOGIC PATIENTS. (23rd June 2022)

Authors:
Sanchez-Paz, L.; Solaeta Gómez, M. J.; Varona Torralvo, N.; Molina Mejías, P.; Valencia Ospina, E.; Rodriguez Calderita, M. A.; Díez Viñas, V.; Ramos de Ascanio, V.; Muñoz Novas, C.; Churruca, J.; Infante, M. S.; Landete, E.; Marín, K.; Foncillas, M. Á.; Hernández-Rivas, J.-Á.; González-Gascón-y-...
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1489
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P622: DOUBLE-HIT TRAF3 DELETION AND MUTATION IDENTIFIED BY HIGH-THROUGHPUT SEQUENCING DEFINE A NEW INDEPENDENT PROGNOSTIC FACTOR IN CHRONIC LYMPHOCYTIC LEUKEMIA. (23rd June 2022)

Authors:
Perez-Carretero, C.; Hernández-Sánchez, M.; Quijada-Álamo, M.; González, T.; Rodríguez-Sánchez, A.; Martín-Izquierdo, M.; Matías-Martín, J.; Rubio, A.; Dávila, J.; García de Coca, A.; Galende, J.; Jimenez-Montero, P.; Queizán, J.-A.; González-Gascón y Marín, I.; Hernández-Rivas, J.-Á.; Benito, R....
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
521
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. S209: PRIMARY RESULTS FROM THE PHASE 3 SHINE STUDY OF IBRUTINIB IN COMBINATION WITH BENDAMUSTINE-RITUXIMAB (BR) AND R MAINTENANCE AS A FIRST-LINE TREATMENT FOR OLDER PATIENTS WITH MANTLE-CELL LYMPHOMA. (23rd June 2022)

Authors:
Wang, M. L.; Jurczak, W.; Jerkeman, M.; Trotman, J.; Zinani, P. L.; Belada, D.; Boccomini, C.; Flinn, I. W.; Giri, P.; Goy, A.; Hamlin, P. A.; Hermine, O.; Hernández-Rivas, J.-Á.; Hong, X.; Kim, S. J.; Lewis, D.; Mishima, Y.; Özcan, M.; Perini, G. F.; Pocock, C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
110
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search